Literature DB >> 3460974

Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma.

D O Olson, A F Shields, C J Scheurich, B A Porter, A A Moss.   

Abstract

Magnetic resonance imaging (MRI) of the bone marrow was performed in 29 patients with leukemia, aplastic anemia, or lymphoma who were scheduled for bone marrow transplantation, and in 12 normals. T1-weighted coronal images (TR600/TE40) of the pelvis and proximal femurs demonstrated marrow pathology in adult patients. A simple MR grading system was developed to classify patterns of marrow involvement, and MR grading of cellularity was correlated with marrow histology. Normal marrow produced a relatively high signal intensity reflecting the predominance of short T1 fat in the marrow space. MRI of pretransplant patients with chronic myelogenous leukemia and acute leukemia in relapse demonstrated a markedly decreased marrow signal, consistent with the replacement of marrow fat by longer T1 neoplastic tissues. Aplastic anemia could not be differentiated from normal with the pulse sequences employed. Marrow involvement by Hodgkin's lymphoma was detected as diffuse marrow infiltration with superimposed focal areas of even lower signal intensity, reflecting the nodular nature of Hodgkin's. These results indicate that infiltrative marrow disorders can be sensitively detected by MRI.

Entities:  

Mesh:

Year:  1986        PMID: 3460974     DOI: 10.1097/00004424-198607000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  14 in total

1.  Variability in the enhancement of the normal central skull base in children.

Authors:  G R Applegate; W L Hirsch; L J Applegate; H D Curtin
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  Characterization of benign and metastatic vertebral compression fractures with quantitative diffusion MR imaging.

Authors:  Xiaohong Joe Zhou; Norman E Leeds; Graeme C McKinnon; Ashok J Kumar
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

3.  Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.

Authors:  A Widding; J Smolorz; M Franke; A Linden; V Diehl; H Schicha
Journal:  Eur J Nucl Med       Date:  1989

4.  Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy.

Authors:  S L Hanna; B D Fletcher; D L Fairclough; J H Jenkins; A H Le
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

5.  Comparison of radiolabeled monoclonal antibody and magnetic resonance imaging in the detection of metastatic neuroblastoma in bone marrow: preliminary results.

Authors:  B D Fletcher; F D Miraldi; N K Cheung
Journal:  Pediatr Radiol       Date:  1989

6.  MRI of the knee region in leukemic children. Part I. Initial pattern in patients with untreated disease.

Authors:  K Bohndorf; G Benz-Bohm; W Gross-Fengels; F Berthold
Journal:  Pediatr Radiol       Date:  1990

7.  MRI of extradural spinal tumours at 0.3 T.

Authors:  M H Li; S Holtås; E M Larsson
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Contrast-enhanced MRI of healed pathologic vertebral compression fracture mimicking active disease in a patient treated for lymphoma.

Authors:  J Li; F O Tio; J R Jinkins
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

9.  Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging.

Authors:  W U Knauf; F Gückel; H Döhner; W Semmler; L Trümper; A D Ho
Journal:  Klin Wochenschr       Date:  1991-05-24

10.  Leukemic red bone marrow changes assessed by magnetic resonance imaging and localized 1H spectroscopy.

Authors:  F Schick; H Einsele; H Bongers; W I Jung; M Skalej; S Duda; G Ehninger; O Lutz
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.